Clinical Trial Update: Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study

View source ↗

Summary

The CAPRICORN-CRS trial investigating calcium, phosphate, renal impairment and coronary artery disease in cardio-renal syndrome for heart failure has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Heart Failure | Status: WITHDRAWN